trending Market Intelligence /marketintelligence/en/news-insights/trending/aXPWbKmGMxdOeWeuQ6zXww2 content esgSubNav
In This List

IRDAI approves Max India's stake divestment in Max Bupa

Case Study

A Prestigious Global Business School Gains a Competitive Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Beyond ESG with Climate Stress Testing: Getting Practical at Banks & Insurers


IRDAI approves Max India's stake divestment in Max Bupa

The Insurance Regulatory and Development Authority of India approved True North Fund VI LLP's purchase of Max India Ltd.'s 51% stake in Max Bupa Health Insurance Co. Ltd.

Max India announced the all-cash transaction in February. The acquisition, which is now set to close within the next few weeks, valued Max Bupa at an enterprise value of 10.01 billion rupees.

Max Bupa is a joint venture between U.K.-based Bupa and Max India.

As of Dec. 2, US$1 was equivalent to 71.66 Indian rupees.